Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.

Mostaghimi A, Gooderham MJ, Lynde C, Sinclair R, King B, Hordinsky M, Rudnicka L, Guttman-Yassky E, Serrao R, Ohyama M, Zhang X, Magnolo N, Kwon O, Oddi C, Meerwein S, Soliman AM, Bu X, Duan C, Wu T, Teixeira HD, Lazar A, Passeron T

Open source

DOI: 10.1001/jamadermatol.2026.2853
Published: 2026 Aug 12
Container: JAMA dermatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1001/jamadermatol.2026.2853,
  title = {Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.},
  author = {Mostaghimi A and Gooderham MJ and Lynde C and Sinclair R and King B and Hordinsky M and Rudnicka L and Guttman-Yassky E and Serrao R and Ohyama M and Zhang X and Magnolo N and Kwon O and Oddi C and Meerwein S and Soliman AM and Bu X and Duan C and Wu T and Teixeira HD and Lazar A and Passeron T},
  year = {2026},
  journal = {JAMA dermatology},
  doi = {10.1001/jamadermatol.2026.2853},
  url = {https://doi.org/10.1001/jamadermatol.2026.2853}
}

RIS

TY  - JOUR
TI  - Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.
AU  - Mostaghimi A
AU  - Gooderham MJ
AU  - Lynde C
AU  - Sinclair R
AU  - King B
AU  - Hordinsky M
AU  - Rudnicka L
AU  - Guttman-Yassky E
AU  - Serrao R
AU  - Ohyama M
AU  - Zhang X
AU  - Magnolo N
AU  - Kwon O
AU  - Oddi C
AU  - Meerwein S
AU  - Soliman AM
AU  - Bu X
AU  - Duan C
AU  - Wu T
AU  - Teixeira HD
AU  - Lazar A
AU  - Passeron T
PY  - 2026
JO  - JAMA dermatology
DO  - 10.1001/jamadermatol.2026.2853
UR  - https://doi.org/10.1001/jamadermatol.2026.2853
ER  -

APA

A, M., MJ, G., C, L., R, S., B, K., M, H., L, R., E, G., R, S., M, O., X, Z., N, M., O, K., C, O., S, M., AM, S., X, B., C, D., T, W., HD, T., A, L., & T, P. (2026). Upadacitinib for Severe Alopecia Areata in Adults and Adolescents: Two Phase 3 UP-AA Randomized Clinical Trials.. JAMA dermatology. https://doi.org/10.1001/jamadermatol.2026.2853

Source records

pubmed · retrieved 2026-09-25T02:19:28.488Z
europe-pmc · retrieved 2026-09-25T02:19:28.512Z